Literature DB >> 18977342

The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.

Natasza A Kurpios1, Lesley MacNeil, Trevor G Shepherd, David W Gludish, Andrew O Giacomelli, John A Hassell.   

Abstract

The Pea3 Ets transcription factor is overexpressed in breast tumors suggesting that it plays a role in mammary oncogenesis. However, the normal biological function of Pea3 in the mammary gland is not known. Here we report that Pea3 was expressed in the epithelium of the mouse mammary anlagen commensurate with their genesis, and at later times in the nipple and mammary ducts of female embryos. In adult mice Pea3 transcripts peaked at the onset of puberty and early pregnancy, times of active epithelial cell proliferation and differentiation. Pea3 was expressed in all progenitor cap cells and rare body cells of terminal end buds, and in the myoepithelial cells of ducts and alveoli. Analyses of the mammary glands of Pea3-null mice during puberty revealed an increased number of terminal end buds and an increased fraction of proliferating progenitor cells within these structures compared to their wild type littermates. Tissue transplant experiments demonstrated that these phenotypes were intrinsic to the Pea3-null mammary epithelium. During pregnancy, mammary glands isolated from Pea3-null females had impaired alveolar development as revealed by a decreased fraction of alveolar structures. We performed in vitro colony forming assays of mammary epithelial cells and discovered that loss of Pea3 altered the distribution of specific multipotent progenitor cells. Double-immunofluorescence confirmed that multipotential progenitors co-expressing markers of the myoepithelial and luminal epithelial lineage were amplified in the mammary glands of Pea3-null mice by comparison to their wild type counterparts. We propose that Pea3 functions in multipotential progenitors to regulate their lineage-specific differentiation potential.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18977342     DOI: 10.1016/j.ydbio.2008.09.033

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  17 in total

1.  Expanding Sca-1(+) mammary stem cell in the presence of oestrogen and growth hormone.

Authors:  Xiaowei Dou; Bin Zhang; Rui Liu; Jing Li; Dan Shi; Chunhua Lu; Xishan Zhu; Lianming Liao; Zhijian Du; Robert Chunhua Zhao
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

Review 2.  The epigenetic landscape of mammary gland development and functional differentiation.

Authors:  Monique Rijnkels; Elena Kabotyanski; Mohamad B Montazer-Torbati; C Hue Beauvais; Yegor Vassetzky; Jeffrey M Rosen; Eve Devinoy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-02-17       Impact factor: 2.673

3.  Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction.

Authors:  David Euhus; Dawei Bu; Xian-Jin Xie; Venetia Sarode; Raheela Ashfaq; Kelly Hunt; Weiya Xia; Joyce O'Shaughnessy; Michael Grant; Banu Arun; William Dooley; Alexander Miller; David Flockhart; Cheryl Lewis
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-21

4.  Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression.

Authors:  Cecilia Williams; Luisa Helguero; Karin Edvardsson; Lars-Arne Haldosén; Jan-Ake Gustafsson
Journal:  Breast Cancer Res       Date:  2009-05-08       Impact factor: 6.466

5.  Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouse.

Authors:  Sara Khalil; Grace A Tan; Dilip D Giri; Xi Kathy Zhou; Louise R Howe
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

6.  The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.

Authors:  Richard Keld; Baoqiang Guo; Paul Downey; Christian Gulmann; Yeng S Ang; Andrew D Sharrocks
Journal:  Mol Cancer       Date:  2010-12-09       Impact factor: 27.401

7.  Dynamic modification of the ETS transcription factor PEA3 by sumoylation and p300-mediated acetylation.

Authors:  Baoqiang Guo; Niki Panagiotaki; Stacey Warwood; Andrew D Sharrocks
Journal:  Nucleic Acids Res       Date:  2011-05-04       Impact factor: 16.971

8.  Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.

Authors:  Robin M Hallett; Maria K Kondratyev; Andrew O Giacomelli; Allison M L Nixon; Adele Girgis-Gabardo; Dora Ilieva; John A Hassell
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

9.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

10.  Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hosts.

Authors:  Natasza A Kurpios; Adele Girgis-Gabardo; Robin M Hallett; Stephen Rogers; David W Gludish; Lisa Kockeritz; James Woodgett; Robert Cardiff; John A Hassell
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.